Coming soon here! I’m going out with a bang! And I am starting up a new project with a bang! The sub title of my blog states “For catalysts in a hurry”. Staying true to this message, I will experiment with a new concept as of October 2020. I take it as a challenge to create this new concept to reflect my innovation knowledge and experience and to present this as a meaningful message. This new series will be original, engaging, dynamic and fun. It will be based on feedback from you, reader of my blog. It will be in line with my focus on coaching corporate Innovation Leaders, especially…
-
-
# 100
Coaching Innovation Leaders When I started blogging in 2018, I committed myself to publish a new blog each Wednesday. I didn’t expect to write 100 of them. Thank you, reader, for your interest, comments and “likes”! As I celebrate this occasion (virtually, masked and with geographic distancing 😊), I take the opportunity to share more about my recent decision to narrow my consulting towards coaching corporate Innovation Leaders, especially in global Pharma/healthcare. Why? It’s the part I liked most in my previous job as global Innovation Leader in Pharma. I enjoyed connecting with colleagues from across the globe to share and to learn. Every problem was unique and it was…
-
Access
Innovative affordability experiments Biologics are medicines that are produced from living organisms or contain components of living organisms. They are very complicated drugs to manufacture and are therefore very expensive. This is why it is often a challenge for patients to pay for them and why it is not sustainable for Pharma companies to provide them for free or even at low cost. This high cost is especially problematic in countries where these medicines need to be paid for out-of-pocket, i.e. where patients are not reimbursed by governments or health insurance organizations. In the past, most of these patients could not benefit from groundbreaking new medicines. Following are 2 examples…
-
Better call SAL
Optimizing external contacts Innovation can originate from anywhere in the corporation. In some cases internal innovators reach out to other companies for collaboration and access to skills or technologies. As a global Innovation Leader of course I encouraged this practice. In many cases, these collaborations resulted in new ways of looking at our business/customer problems and generated innovative solutions. For example: application of emerging technologies that had not yet been used in our corporation, like AI, robotics and drones. However, as the number of innovators within our corporation grew exponentially, the following often happened. An innovator in a certain geography worked with a certain external company from that same location.…
-
Invented here!
Innovation from within corporations. Innovative ideas can come from everywhere: from the employees inside the corporation or from outside the corporation. Each source has pros and cons and they can co-exist. As Innovation Leader in a large corporation, I focused on internal innovation. First, because this was part of the original briefing I got from my leadership: “we know that there is a lot of innovation happening across our organization, we need someone to identify those innovations and bring us the most valuable ones”. Second, because of the following 3 selected benefits of internal innovation. I am also adding suggestions on how Innovation Leaders can reap those benefits. Knowledge Compared…